CLGN: CollPlant Biotechnologies Ltd New Company Profile & Statistics

About

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw as CollPlant Holdings Ltd., is based in Rehovot, Israel.

Info & Links

CEO

Yehiel Tal

Headquarters

4 OPPENHEIMER ST., 11TH FLOOR
REHOVOT, L3 7670104, ISRAEL

Auditor

Kost Forer Gabbay & Kasierer

Share holders

Employees

CollPlant Biotechnologies Ltd New Statistics

Valuation Measures

Market Capitalization²

41.79M

Enterprise Value

22.64M

Enterprise Value/EBITDA(ttm)

-1.31

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

65.03

Price to Book(mrq)

2.50

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-1857.48%

Operating Margin(ttm)

-2680.00%

Profit Margin(ttm)

-28922.40%

Return on Equity(ttm)

-77.05%

Return on Invested Capital(ttm)

-79.59%

Return on Assets(ttm)

-61.43%

Income Statement

Revenue(ttm)

689.00K

Revenue Per Share(ttm)

Gross Profit(ttm)

-1.44M

EBITDA(ttm)³

-17.31M

Net Income Available to Common(ttm)

-17.47M

Diluted EPS(ttm)

-1.54

Share Statistics

Beta (5Y Monthly)

0.51

52-Week Change

-30.21%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

10.36M

% Held by Insiders

9.60%

% Held by Institutions

21.69%

Balance Sheet

Total Cash(mrq)

19.16M

Total Cash Per Share(mrq)

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.38%

Quick Ratio(mrq)

5.23%

Book Value Per Share(mrq)

1.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.93

Free Cash Flow(ytd)

-11.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CLGN

CollPlant Biotechnologies Ltd New

CollPlant Biotechnologies Ltd New Profile